Tasman Medical Journal

ISSN:  2652-1881

Volume 2024 - Issue 3.

The myth of hydroxychloroquine in the treatment of SARS-CoV-2 infection

Alasdair Millar

Abstract

There is continuing support for hydroxychloroquine (HCQ) in the treatment of SARS-CoV-2 infection, one recent example in Australia being an article by Professor Robert Clancy in the centre-right monthly magazine Quadrant. Clancy argued that HCQ is effective and that its non-use reflects a conspiracy by the World Health Organisation and the global pharmaceutical industry to control patient care. In this article I review the trial evidence for HCQ efficacy and confirm that it does not support use of HCQ in any phase of COVID infection.

ABSTRACT | FULL TEXT | PDF

Test Pop-up